-
Symbol
-
GTBP on Nasdaq
-
Investment type
-
Equity - Shares of Stock
-
Class
-
Common Stock, par value $0.001
-
Latest Disclosed Ownership
-
219K shares
-
Security Ownership
-
9.8%
CYTOVANCE BIOLOGICS INC ownership in GT Biopharma, Inc. Common Stock, par value $0.001 (GTBP)
2024-10-17 - CYTOVANCE BIOLOGICS INC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 219K shares of GT Biopharma, Inc. Common Stock, par value $0.001 (GTBP).
This represents 9.8% percent ownership of the company.